Quick Detail:
Product Name: | Ponazuril |
Alias: | Toltrazuril sulfone |
Chemical Name: | 1-methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione |
Structural Formula: |
|
Molecular Formula: | C18H14F3N3O6S |
Molecular weight: | 457.38000 |
Appearance: | white crystelline powder |
Packing: | 25kg/cardboard drum; 36.5 H47cm |
CAS NO.: | 69004-04-2 |
Specification of Ponazuril:
Items | Specifications | Results |
Character | White or almost white crystalline powder;odorless | white crystelline powder, odorless |
Melting point | 242~246°C | 243.4~244.3°C |
Identification | 1) IR spectra is consistent with CRS | complies |
2) The retention time of the major peak in the chromatogram of the assay preparation corresponds to that in the chromatogram of the standard preparation, as obtained in the assay | complies | |
Appearance of solution | colorless and clear liquid | colorless and clear liquid |
Related substances | individual impurity≤1.0% | 0.24% |
Total impuirties ≤2.0% | 0.70% | |
Loss on ignition | ≤0.5% | 0.32% |
Residue on ignition | ≤0.1% | 0.05% |
Heavy metals | Not more than 10 parts per million | Less than 10 parts per million |
Assay | Not less than 98.0% of C18H14F3N3O6S(On dried basis) | 99.40% |
Conclusion: | Complies with Ponazuril Enterprise Standard |
Usage for Ponazuril:
1) Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.
2) Veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and
dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.